Sacchini, Dario
 Distribuzione geografica
Continente #
EU - Europa 11.348
NA - Nord America 9.892
AS - Asia 6.198
SA - Sud America 1.374
AF - Africa 199
OC - Oceania 73
Continente sconosciuto - Info sul continente non disponibili 17
Totale 29.101
Nazione #
US - Stati Uniti d'America 9.527
IT - Italia 5.166
SG - Singapore 2.725
DE - Germania 1.645
CN - Cina 1.618
BR - Brasile 1.103
SE - Svezia 994
FR - Francia 882
UA - Ucraina 516
VN - Vietnam 512
GB - Regno Unito 463
IE - Irlanda 323
PL - Polonia 229
NL - Olanda 225
CA - Canada 215
IN - India 215
ID - Indonesia 207
FI - Finlandia 174
RU - Federazione Russa 153
GR - Grecia 130
HK - Hong Kong 127
BD - Bangladesh 121
JP - Giappone 121
TR - Turchia 110
AR - Argentina 93
MX - Messico 66
AU - Australia 64
BE - Belgio 63
CH - Svizzera 59
ES - Italia 57
RO - Romania 51
KR - Corea 50
ZA - Sudafrica 50
IQ - Iraq 49
IR - Iran 46
PK - Pakistan 38
AT - Austria 37
SA - Arabia Saudita 36
CO - Colombia 35
EC - Ecuador 35
CZ - Repubblica Ceca 33
CL - Cile 28
PE - Perù 28
NO - Norvegia 26
VE - Venezuela 23
KE - Kenya 22
MA - Marocco 22
CI - Costa d'Avorio 21
IL - Israele 20
JM - Giamaica 20
PH - Filippine 20
DK - Danimarca 19
NP - Nepal 17
MY - Malesia 16
TW - Taiwan 15
DZ - Algeria 14
GE - Georgia 14
PT - Portogallo 14
AE - Emirati Arabi Uniti 13
EU - Europa 13
UZ - Uzbekistan 13
BH - Bahrain 12
EG - Egitto 12
PA - Panama 12
PY - Paraguay 12
TN - Tunisia 12
AL - Albania 11
CR - Costa Rica 11
LT - Lituania 11
TH - Thailandia 11
JO - Giordania 10
NZ - Nuova Zelanda 9
TT - Trinidad e Tobago 9
UY - Uruguay 9
HU - Ungheria 8
KZ - Kazakistan 8
NG - Nigeria 8
AZ - Azerbaigian 7
BA - Bosnia-Erzegovina 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
LK - Sri Lanka 6
OM - Oman 6
VA - Santa Sede (Città del Vaticano) 6
BO - Bolivia 5
HR - Croazia 5
LV - Lettonia 5
MD - Moldavia 5
PS - Palestinian Territory 5
SI - Slovenia 5
BB - Barbados 4
BS - Bahamas 4
BW - Botswana 4
EE - Estonia 4
HN - Honduras 4
KG - Kirghizistan 4
KW - Kuwait 4
LS - Lesotho 4
QA - Qatar 4
Totale 29.022
Città #
Singapore 1.279
Ashburn 1.110
Chandler 932
Rome 760
San Jose 745
Milan 531
Jacksonville 398
Dublin 307
Beijing 299
Nanjing 247
San Mateo 242
Wilmington 196
Houston 190
Ann Arbor 182
Cattolica 181
New York 180
Jakarta 179
Lauterbourg 179
Ho Chi Minh City 167
Redwood City 159
Los Angeles 152
Woodbridge 152
Kraków 149
Munich 138
Hanoi 135
São Paulo 110
Fairfield 107
Tokyo 105
Boston 104
Nanchang 102
The Dalles 102
Dearborn 101
Marseille 101
Turin 97
Hefei 95
Hong Kong 94
Lawrence 90
Dallas 89
Moscow 86
Seattle 83
Frankfurt am Main 79
Boardman 77
Bologna 73
Chicago 73
Naples 68
Princeton 66
Buffalo 65
Florence 64
Kunming 62
Palermo 56
Bremen 53
Cambridge 52
Izmir 52
Santa Clara 51
Nürnberg 49
Atlanta 47
Lancaster 47
London 47
Redmond 47
Paris 46
Athens 44
Brussels 43
Mountain View 43
Brooklyn 42
Guangzhou 42
Basingstoke 41
Helsinki 41
Rio de Janeiro 40
Warsaw 39
Norwalk 38
Amsterdam 37
Denver 37
Toronto 35
Tianjin 34
Tukwila 34
Bari 31
Seoul 31
Thessaloniki 31
Changsha 28
Hangzhou 28
Hebei 28
Shanghai 28
Shenyang 28
Brescia 27
University Park 27
Washington 27
Catania 26
Council Bluffs 26
Fremont 26
Orem 26
Da Nang 25
Philadelphia 25
Charlotte 24
Chennai 24
Lima 24
Zurich 24
Berlin 23
Haiphong 23
Jiaxing 23
Manchester 23
Totale 13.075
Nome #
Il personalismo ontologicamente fondato come approccio per le analisi etiche nei processi di HTA 2.090
Ethical, Legal, and Social Assessment of AI-Based Technologies for Prevention and Diagnosis of Rare Diseases in Health Technology Assessment Processes 965
Principio di socialità 812
Guidance on choosing qualitative evidence synthesis methods for use in health technology assessments of complex interventions 521
Food safety and nutritional habits in elderly: knowledge to promoting active ageing 409
HTA of alternative methods of pathogen inactivation of fresh frozen plasma 289
Food safety perception and nutritional habits in elderly: preliminary results of a pilot study to know the needs and promote active ageing 272
Insurance and clinical trials 269
EUnetHTA Joint-Action 1. HTA Core Model Application for Diagnostic Technologies (1.1). Prognostic tests for breast cancer recurrence (uPA/PAI-1 [FEMTELLE], MammaPrint, Oncotype DX). Ethical analysis 263
La ética de la experimentación en el hombre del proceso de Núremberg a los comités de ética 255
Le esperienze di analisi ELSI in processi di HTA dell’Istituto di Bioetica e Medical Humanities dell’Università Cattolica del Sacro Cuore di Roma: un aggiornamento 255
La consulenza bioetica al letto del malato: l’esperienza del Servizio di Etica clinica presso la Fondazione Policlinico Universitario “Agostino Gemelli” IRCCS –Roma 251
The ethical assessment in HTA reports: the development and the evolution of the ethics consultation by Institute of Bioethics of the Università Cattolica del Sacro Cuore, Rome (Italy) 249
Allogeneic versus Autologous: ethical issues in umbilical cord blood use 239
Full HTA di Emicizumab 237
Radio-223 nel trattamento del carcinoma della prostata metastatico resistente alla castrazione (mCRPC): risultati di una valutazione di Health Technology Assessment 227
The ethical relevance of explainibility for AI-solutions for early diagnosis of dementia 224
The “triangular model” applied to drug eluting stents (DES) 223
Linee guida sull'inizio e la sospensione del trattamento emodialitico 220
How could Ethical, Legal, Social & Organizational issues be further integrated in HTA processes? A proposal of “extended” ELSI logics: justifications and considerations moving from the debate and the experience. 213
Introduction to Ethics in Health Technology Assessment. HTAi 2021 Annual Meeting 213
Le procedure operative nella consulenza di etica clinica: l’esperienza del Servizio di Bioetica clinica presso la Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Università Cattolica del Sacro Cuore, Roma (IT) 209
Health Technology Assessment di ausili assorbenti per l’incontinenza urinaria 202
Ethical evaluation of risks related to living donor transplantation programs 199
Ruolo ed attività di un Comitato di Bioetica in un Centro di cure palliative: l’esperienza di Antea 198
Male fertility and reduction in semen parameters: A single tertiary-care center experience 195
Un altro tipo di consulenza etica in ambito sanitario: l’analisi etica nei processi di Health Technology Assessment (HTA) 195
Triage in emergenza pandemica: sui rischi di una carrellologia 195
Il ruolo dei Real World Data (RWD) nell’Health Technology Assessment (HTA). La lezione della filosofia della scienza e del Progetto VALIDATE 194
Lo sviluppo della consulenza etica nei processi di HTA: i dati preliminari dell'esperienza dell'Istituto di Bioetica dell'Università Cattolica del Sacro Cuore (Roma) 194
Analisi etica. Report HTA del vaccino quadrivalente ad alto dosaggio (QIV-HD) EFLUELDA® per la prevenzione dell’influenza stagionale e delle sue complicanze nella popolazione over 65 194
The retrieval and critical appraisal of literature on patient preferences for treatment outcomes 192
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use 190
Clinical ethics consultation as “shared document”. Emerging ethical and medico-legal issues: Sacchini D., Corsano B., Refolo P., Minacori R., Spagnolo A.G.the experience of IBioMedH-UCSC CEC Service (2005-2016) 187
RAPID RELATIVE EFFECTIVENESS ASSESSMENT OF NEW PHARMACEUTICALS FOR THE TREATMENT OF CHRONIC HEPATITIS C.POTENTIAL ETHICAL, ORGANISATIONAL, SOCIAL, AND LEGAL ASPECTS 186
I moduli informativi e di espressione del consenso in cure palliative: una valorizzazione dei percorsi relazionali. L'esperienza di Antea 184
Il timore del contenzioso e il Giuramento di Ippocrate 181
Factors affecting safe and healthy diet in older adults in Italy: Results of a preliminary study performed in a community-dwelling sample 181
Health Technology Assessment di icodec per la gestione dei pazienti affetti da diabete in Italia 179
Exploring the ethical issues of digital therapeutics (DTx) 177
Aspetti sociali. Report HTA del vaccino quadrivalente ad alto dosaggio (QIV-HD) EFLUELDA® per la prevenzione dell’influenza stagionale e delle sue complicanze nella popolazione over 65 172
Prioritization of high-cost new drugs for HCV: making sustainability ethical 171
E-recruitment based clinical research: notes for Research Ethics Committees/Institutional Review Boards 169
Il Documento Condiviso di Orientamento Etico Assistenziale nella Consulenza di Etica Clinica 169
De la moral médica a la bioética clínica 168
Le valutazioni etiche e quelle di HTA confermano il profilo di efficacia e sicurezza delle nuove terapie 167
Aspetti legali. Report HTA del vaccino quadrivalente ad alto dosaggio (QIV-HD) EFLUELDA® per la prevenzione dell’influenza stagionale e delle sue complicanze nella popolazione over 65 167
Ethical evaluation of risks related to living donor transplantation programs 166
Electronic Medical Diary (EMD): ethical analysis in a HTA process 166
Health Technology Assessment of the anti HCV strategies in Italy: evidences from the WEF Project 165
Introduction to Ethics in Health Technology Assessment 164
The ethical assessment of nanotechnologies within HTA processes 163
Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system 160
Le analisi etiche nei processi di HTA nell'esperienza dell'Istituto di Bioetica della Facoltà di Medicina e chirurgia “A. Gemelli” dell'Università Cattolica del Sacro Cuore di Roma 158
Ethical aspects of Fecal Microbiota Transplantation (FMT) 157
Aspetti bioetici della gestione delle epatiti in Italia 156
THE ETHICAL DOMAIN IN HEALTH TECHNOLOGY ASSESSMENT (HTA): BASICS, APPROACHES AND ISSUES 155
HTA processes for nanotechnologies: the ethical domain. 154
A risk adapted approach to the governance of clinical trials 154
L’uso di Internet nei trial clinici 154
Costs of new anti Hepatitis C regimens and access to care: the case for prioritization or universal cure 151
L’arte e la scienza delle biobanche 150
The clinical ethics consultation (CEC): clarification tool for physicians and patients to avoid complaints? 149
Theories of technological development and HTA 149
Valutazione multidimensionale e multidisciplinare del servizio di consegna domiciliare dei presidi medici per stomia e incontinenza 149
Ética y colocación de los recursos en la salud 148
Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors 148
Italian Palliative Care Services: The Role of Patients' and Professionals' Views in Health Technology Assessment Scope Development 147
Digital Technology and Healthcare: The Role of Health Technology Assessment 147
The Legislation on Living Organ Donation in Western Europe: Legal and Ethical Analysis and Impact on Clinical Practice 146
Integrated assessment of home based palliative care with and without reinforced caregiver support: ‘A demonstration of INTEGRATE-HTA methodological guidances’ – Executive Summary 145
Why teach “Bioethics and Human Rights” to healthcare professions undergraduates? / Zašto predavati „Bioetiku i ljudska prava“ studentima zdravstvenih studija 145
Why is it difficult to integrate ethics in HTA?. The epistemological viewpoint 145
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 144
Budget Impact Analysis of Fingolimod in Relapsing Remitting Multiple Sclerosis 143
Which kind of ethical issues in HTA processes? Results and considerations from the application of ethics expertise in HTA processes in Italy 141
Giustizia intergenerazionale in sanità. Il caso della valutazione dei “farmaci insostenibili 140
Ethics and economics: the case of prenatal technologies. HTA for evidence-based public health 139
Newborn with Ohtahara Syndrome and absence of respiratory trigger: ethical issues in the NICU|Neonata con Sindrome di Ohtahara e assenza di trigger respiratorio: questioni etiche in Terapia Intensiva Neonatale 138
Using the best available evidence to inform decision making on complex interventions: Building the future through increasing public and patient involvement in Health Technology Assessment. 137
Economic assessment of Eltrombopag in the treatment of thrombocytopenia 137
Chapter 2. The fact/value dichotomy 136
Ethics of digital therapeutics (DTx) 133
The ethical assessment of nanotechnologies for HTA 133
The ethical and legal implications of nanotechnologies: a preliminary survey to picture the perceptions of law students and medical students. 132
Il dibattito etico-deontologico sul compenso economico per la donazione di sangue 131
Research Ethics Committees and clinical research in Italy: where are we going? 131
Etica e HTA: sulle difficoltà epistemologiche della loro integrazione 131
Sustainability of national health services and justice: the case of new DAAs for HCV in Italy 131
VALIDATE consensus statement: integrating empirical and ethical inquiry in health technology assessment 131
Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors 130
Towards an integrated assessment of complex health interventions. Results of the European INTEGRATE-HTA project 130
IL CONSENSO INFORMATO NELLA CURA DEL PAZIENTE CON FRATTURA DEL FEMORE 129
Health Technology Assessment (HTA): ethical aspects 128
The six-year experience of the Italian Master in “Clinical Bioethics Consultation” (2013-2018) 128
Shared Decision-Making at the End of Life 128
What Type of Person Should I Be? About the Appeal to Virtues in Public Health Interventions 127
Assessing innovative technologies for secondary prevention and diagnosis: the MELCAYA project 125
Should Artificial Intelligence-Based Patient Preference Predictors Be Used for Incapacitated Patients? A Scoping Review of Reasons to Facilitate Medico-Legal Considerations 125
Patients Diagnostic Therapeutic Pathways For Hcv Patients In Italy: Impact Of Regionalization In Treatments And Guidelines. 125
Totale 21.085
Categoria #
all - tutte 100.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.897


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.353 163 134 118 158 197 154 181 327 138 130 330 323
2022/20233.763 448 411 279 470 285 439 250 350 414 108 196 113
2023/20242.705 177 496 95 213 137 273 164 257 99 177 227 390
2024/20254.087 194 196 316 231 401 184 182 210 532 353 693 595
2025/20268.905 1.246 316 460 801 1.325 418 1.343 432 490 670 1.189 215
2026/2027189 189 0 0 0 0 0 0 0 0 0 0 0
Totale 29.488